This content is machine translated Personalized PsA therapy Psoriatic arthritis criterion-guided treatment An overarching principle for therapy selection in psoriatic arthritis is shared decision making with patients. The GRAPPA recommendations propose an individualized treatment approach that takes into account the predominant disease…
View Post 3 min This content is machine translated Psoriatic arthritis (PsoA) Pooled analysis on the efficacy of secukinumab from four phase III studies Improvement in clinical endpoints was seen with secukinumab treatment regardless of latency since initial psoriatic arthritis diagnosis, with patients diagnosed less than one year ago showing a slightly better response…
View Post 4 min This content is machine translated Systemic lupus erythematosus Innovative therapeutic approaches on the rise – pioneering new treatment strategies Systemic lupus erythematosus (SLE) carries a high risk of life-threatening organ damage, but there is new hope for sufferers. In recent years, the development of innovative treatment options has been…
View Post 3 min This content is machine translated Psoriasis: disease management during corona pandemic “Shared decision making” is especially important in these times Among psoriasis patients, there is often some uncertainty about the implications of their underlying disease and the respective system therapy with regard to the risk of a severe course of…
View Post 4 min This content is machine translated Comorbidity Research Psoriasis as a systemic disease – study findings on comorbid depression Psoriasis and psoriatic arthritis (PsoA) often have a significant impact on the daily life and quality of life of those affected. The prevalence of mental health comorbidities is increased, with…
View Post 5 min This content is machine translated Interview with Prof. Dr. med. Pascal Richette Facing the challenges of psoriatic arthritis management Despite remarkable progress in the treatment of patients with psoriatic arthritis (PsA), the management of this chronic disease still poses major challenges [1]. In the following interview, Prof. Pascal Richette,…
View Post 4 min This content is machine translated Osteopenia Prevent bone loss – avoid vitamin D deficiency Osteoporosis and osteomalacia are two metabolic bone diseases that reduce bone mass. In osteoporosis, there is a decrease in bone mass, but the ratio between bone mineralization and bone matrix…
View Post 9 min This content is machine translated Mild to moderate psoriasis vulgaris Swiss treatment pathway for topical psoriasis therapy 2021 Topical treatment of plaque psoriasis has a high priority in the everyday clinical practice. In mild symptoms, topical topical preparations are the mainstay of therapy; in moderate to severe cases, they…
View Post 7 min This content is machine translated Gout Management in practice Once called the “disease of kings,” gout is now a common disease due to prosperity. The genetic predisposition for the metabolic disorder is inherited, but various conditions come together for…
View Post 6 min This content is machine translated Psoriatic arthritis (PsA) Health-related quality of life in PsA – validation of the German version of the PsAQoL. The course of psoriatic arthritis has a significant impact on the quality of life of those affected. The German version of the PsAQoL questionnaire is an empirically validated measurement instrument…
View Post 2 min This content is machine translated Plaque psoriasis Secukinumab ready-to-use 300 mg injection convinces The EMA-approved new route of administration for the IL-17A inhibitor allows the recommended dosage to be administered in a single injection. Data analyses of the pivotal phase IIIb MATURE study…
